SCHEMBL6479157

SCHEMBL6479157

COCOc1ccc(-c2ccc(C)cc2)c(C=O)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FYN P06241 5/20 0.40
TUBB1 Q9H4B7 1/20 0.37
ERN1 O75460 5/20 0.37
MAOB P27338 3/20 0.37
MAOA P21397 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
EGFR P00533 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 1/20 0.35
RAB9A P51151 1/20 0.35
DUSP3 P51452 1/20 0.35
POLB P06746 1/20 0.35
KDM1A O60341 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7922695 0.89 FYN (0.40) FYNTUBB1ERN1MAOBMAOA
SCHEMBL6473730 0.83 FYN (0.37) FYNMAOBSMN1; SMN2L3MBTL1EGFR
SCHEMBL6473343 0.83 FYN (0.37) FYNMAOBSMN1; SMN2L3MBTL1EGFR
SCHEMBL7931935 0.83 FYN (0.39) FYNMAOBSMN1; SMN2EGFRHPGD
SCHEMBL7931938 0.83 FYN (0.39) FYNMAOBSMN1; SMN2EGFRHPGD
SCHEMBL6472740 0.82 FYN (0.38) FYNMAOBMAOAEGFRRAB9A
SCHEMBL16341868 0.79 TUBB1 (0.42) FYNTUBB1ERN1EGFRALDH1A1
SCHEMBL7931866 0.78 XDH (0.42) FYNERN1SMN1; SMN2EGFRALDH1A1
SCHEMBL7935346 0.76 SRC (0.44) ERN1MAOBMAOASMN1; SMN2L3MBTL1
SCHEMBL16705703 0.75 TUBB1 (0.52) TUBB1ERN1SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037756-A2 NOVEL METHODS FOR THE PREPARATION OF 4-[4-(4-METHOXYMETHOXY-4'-METHYL-BIPHENYL-2-YL)-BUT-3-ENE-(E)-1-YNYL]-BENZOIC ACID GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2005-04-28 WO claimed
WO-2005037756-A2 NOVEL METHODS FOR THE PREPARATION OF 4-[4-(4-METHOXYMETHOXY-4'-METHYL-BIPHENYL-2-YL)-BUT-3-ENE-(E)-1-YNYL]-BENZOIC ACID GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2005-04-28 WO disclosed
EP-0879814-B1 Triaromatic compounds, compositions containing them and uses thereof CT INTERNAT DE BR RECH S DERMA (FR) 2001-11-28 EP disclosed
US-6150413-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, BONE AND OPHTHALMOLOGICAL DISORDERS, AS WELL AS MAMMALIAN SKIN AND HAIR CONDITIONS; 4-(4-(BIPHENYL-2-YL)BUT-3-EN-1-YNYL)BENZOIC ACID, FOR EXAMPLE CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-11-21 US disclosed
EP-0879814-A1 Triaromatic compounds, compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1998-11-25 EP disclosed